Cite
HARVARD Citation
Jennings, S. et al. (2021). Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)—insights of people affected by cancer and healthcare professionals: a qualitative study protocol. BMJ open. 11 (5), p. . [Online].